Similarly, in chronic myeloid leukemia, MTSS1 is downregulated, and re-expression of MTSS1 affects leukemic cell motility, tumor growth, and chronic myeloid leukemia development in vitro (Schemionek et al., 2016). The gene discussed is MTSS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.